Related Experiment Video

Updated: May 10, 2026

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

SYK inhibition modulates distinct PI3K/AKT- dependent survival pathways and cholesterol biosynthesis in diffuse large

Linfeng Chen1, Stefano Monti, Przemyslaw Juszczynski

  • 1Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA.

Cancer Cell
|June 15, 2013
PubMed

Insights

Targeting B cell receptor (BCR) signaling, particularly spleen tyrosine kinase (SYK), offers new therapeutic avenues for diffuse large B-cell lymphoma (DLBCL). This study reveals distinct SYK/PI3K survival pathways and genetic alterations in DLBCL, guiding personalized treatment strategies.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • B cell receptor (BCR) signaling is crucial in B cell malignancies like diffuse large B-cell lymphoma (DLBCL).
  • Spleen tyrosine kinase (SYK) is a key mediator of BCR signaling, representing a potential therapeutic target.
  • Previous research demonstrated SYK inhibition's efficacy in inducing apoptosis in BCR-dependent DLBCLs.

Purpose of the Study:

  • To characterize distinct SYK/PI3K-dependent survival pathways in DLBCL based on NF-κB activity levels.
  • To investigate the role of SYK/PI3K in maintaining BCR integrity within lipid rafts.
  • To identify genetic alterations associated with BCR-type DLBCL.

Main Methods:

  • Analysis of SYK/PI3K-dependent pathways in DLBCL with varying NF-κB activity.
  • Assessment of HRK protein repression in NF-κB-low DLBCL.
  • Investigation of SYK/PI3K-mediated cholesterol biosynthesis and BCR localization in lipid rafts.
  • Identification of genetic alterations such as SYK amplification and PTEN deletion in primary DLBCL samples.

Main Results:

  • Distinct SYK/PI3K survival pathways were identified in DLBCLs with high versus low NF-κB activity.
  • Selective repression of the pro-apoptotic HRK protein was observed in NF-κB-low DLBCL.
  • SYK/PI3K-dependent cholesterol biosynthesis was defined as a mechanism for maintaining BCR integrity in lipid rafts.
  • SYK amplification and PTEN deletion were identified as specific genetic alterations in BCR-type DLBCL.

Conclusions:

  • Understanding the differential SYK/PI3K signaling pathways and genetic landscape in DLBCL is critical for targeted therapy development.
  • Targeting SYK and related pathways, alongside addressing specific genetic alterations, holds promise for improving DLBCL treatment outcomes.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...